Update of faecal markers of inflammation in children with cystic fibrosis.

Jung M Lee, Steven T Leach, Tamarah Katz, Andrew S Day, Adam Jaffe, Chee Y Ooi

Journal: Mediators of inflammation 2013;2012():948367

PMID: 22988347

Free Full Text on PubMed Central View on PubMed

Abstract

There is evidence of intestinal inflammation in patients with CF. Intestinal inflammation may negatively impact the nutritional status of patient with CF, which adversely affects pulmonary function and survival. This paper provides an up-to-date review of intestinal inflammation in CF and an evaluation of utility of two specific faecal inflammatory markers (S100A12 and calprotectin).

Address: School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, High Street, Sydney, NSW, Australia.

DOI: 10.1155/2012/948367

Link outs

Free resources

Full Text Sources:

Medical:

Miscellaneous:

https://assays.cancer.gov/non-CPTAC-1154

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-S100A12-...

MeSH Terms: Biomarkers, Cystic Fibrosis, Feces, Humans, Inflammation, Leukocyte L1 Antigen Complex, S100 Proteins, S100A12 Protein